References
  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians  2021; 71(1):7–33.
  2. Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975–2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
  3. Roush SW, Krischer JP, Pollock NC, Cox MW, Pollock BH, Bayer J. The incidence of pediatric cancer in Florida, 1981-1986.Cancer . 1992 Apr 15;69(8):2212-9.
  4. Krischer JP, Roush SW, Cox MW, Pollock BH Using a population-based registry to identify patterns of care in childhood cancer in Florida. Cancer. 1993 May 15;71(10 Suppl):3331-6.
  5. Roush SW, Krischer JP, Cox MW, et al. Progress in childhood cancer care in Florida. 1970-1992. J Fla Med Assoc . 1993 Nov;80(11):747-51.
  6. Siegel DA, Li J, Henley SJ, Wilson RJ, Lunsford NB, Tai E, Van Dyne EA. Geographic variation in pediatric cancer incidence - United States, 2003-2014. MMWR Morb Mortal Wkly Rep. 2018 Jun 29;67(25):707-713. doi: 10.15585/mmwr.mm6725a
  7. Amin R, Bohnert, Holmes L, Rajasekaran A, Assanasen C. Epidemiologic mapping of Florida childhood cancer clusters. Pediatr Blood Cancer 2010 Apr;54(4):511-8.
  8. Wilkinson JD, Fleming LE, MacKinnon J, Voti L, Wohler-Torres B, Peace S, Trapido E. Lymphoma and lymphoid leukemia incidence in Florida children: ethnic and racial distribution. Cancer, 2001:91(7):1402-1408.
  9. Giddings BM, Whitehead TP, Metayer C, Miller MD. Childhood leukemia incidence in California: High and rising in the Hispanic population. Cancer, 2016:122(18):2867-2875.
  10. Marcotte EL, Domingues AM, Sample JM, Richardson MR, Spector LG. Racial and ethnic disparities in pediatric cancer incidence among children and young adults in the United States by single year of age. Cancer, 2021:127(19):3651-3663.
  11. Lund MJ, Eliason MT, Haight AE, Ward KC, Young JL, Pentz RD. Racial/ethnic diversity in children’s oncology clinical trials: ten years later. Cancer. 2009 Aug 15;115(16):3808-16. doi: 10.1002/cncr.24437.
  12. Shaw PH, Ritchey AK. Different Rates of Clinical Trial Enrollment between Adolescents and Young Adults Aged 15 to 21 Years-Old and Children Under 15 Years-Old with Cancer at a Children’s Hospital. J Pediatr Hematol Oncol, 2007:29(12):811-814.
  13. Jacob SA, Shaw PH. No improvement in clinical trial enrollment for adolescents and young adults with cancer at a children’s hospital. Pediatr Blood Cancer. 2017 Dec;64(12).
  14. Faulk KE, Anderson-Mellies A, Cockburn M, Green ML. Assessment of enrollment characteristics for Children’s Oncology Group (COG) upfront therapeutic clinical trials 2004-2015. PLoS One. 2020 Apr 23;15(4):e0230824. doi: 10.1371/journal.pone.0230824. eCollection 2020.
  15. Smith MA, Seibel NL, Altekruse SF et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. .J Clin Oncol. 2010 May 20;28(15):2625-34.
  16. Pui CH, Pei D, Pappo AS, et al. Treatment outcomes in black and white children with cancer: results from the SEER database and St. Jude Children’s Research Hospital, 1992 through 2007. J Clin Oncol. 2012 Jun 1;30(16):2005-12.